Sentient Synthetics

AI-based Digital Pathology Solutions

Health Tech & Life Sciences
Active
Pre-Seed Herzliya, Israel Founded 2021
Last updated 2026-06-18
Total raised
$250K
Last: 2021-09
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences

About

Sentient Synthetics is an AI-based, digital pathology company leveraging machine learning to create synthetic pathology datasets for the purpose of overcoming existing data limitations in the field of computational pathology. These synthetic datasets are validated, affordable, thoroughly labeled, and free from privacy concerns. They aim to enable faster and more accurate training and validation for highly accurate AI algorithms by medical research centers, digital health, pharmaceutical companies, and diagnostics, for all cancer tissue types, including the rarer forms. Sentient is a Technion spin-off company.

Funding history · 1 round · $250K total

2021-09
$250K

Q&A

What is Sentient Synthetics' primary focus?
Sentient Synthetics is an AI-based, digital pathology company that uses machine learning to create synthetic pathology datasets. These datasets aim to overcome data limitations in computational pathology and enable faster, more accurate training and validation for AI algorithms in medical research, digital health, pharmaceutical companies, and diagnostics for various cancer tissue types.
When was Sentient Synthetics founded?
Sentient Synthetics was founded in May 2021.
How much funding has Sentient Synthetics raised to date?
Sentient Synthetics has raised a total of $250,000.
Which investor participated in Sentient Synthetics' funding round?
aMoon Fund participated in Sentient Synthetics' funding round in September 2021.
What is the current employee count for Sentient Synthetics?
Sentient Synthetics has 1-10 employees.
Who are the founders of Sentient Synthetics?
The founders of Sentient Synthetics include Prof. Yonatan (Yoni) Savir, who serves as Founder & CSO, and Fabian Schvartzman, who serves as Co-founder & CEO.
What is Sentient Synthetics' current product stage?
Sentient Synthetics is currently in the R&D product stage.
What is Sentient Synthetics' primary sector?
Sentient Synthetics' primary sector is Health Tech & Life Sciences.

Team · 1

Founder · Founder & CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Enterprise & Professional ServicesHealthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Tags

enterprise-solutionssynthetic-datadiagnosticspharma-companiessoftware-platformhealthcare-providersmachine-learningartificial-intelligencedigital-healthcarecancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesentient-med.com
LinkedInlinkedin.com/company/76520188

Identifiers & details

Former namesRivas AI
Founded2021-5
Employees (exact)6

Radar intelligence

Web history (Wayback)

Domainsentient-med.com

Certificate / subdomain footprint

Subdomains1